2 Kyrgyz Nationals Held With Medicines Worth Rs 25 Lakh At Delhi Airport

New Delhi: Two Kyrgyzstan nationals carrying anti-epileptic Reagapen 300 mg Capsules worth about Rs 25 lakh were apprehended by CISF personnel at the Delhi airport on Monday, officials said.

The duo were intercepted by the security personnel around noon at terminal 3 of the Indira Gandhi International (IGI) airport after their movement was found to be suspicious, a Central Industrial Security Force (CISF) officer said.

Five large trolley bags stuffed with a huge quantity of Regapen 300 mg capsules were recovered from the two passengers, who are Kyrgyzstan nationals, he said.

They were bound for Almaty onboard an Air Astana plane scheduled to depart from the IGI airport at 3 pm. Regapen is an anti-epileptic drug and anti-narcotics officials say it is also abused as a psychotropic substance.

“As the passengers could not produce a valid authorisation for carrying such a huge quantity of medicines, they were offloaded from the plane and handed over to customs officials,” the officer said.

The CISF provides a counter-terrorist and counter-sabotage cover to the Delhi airport.

Related Posts

  • Pharma
  • July 27, 2024
  • 37 views
Mankind Pharma Acquires Bharat Serums And Vaccines For Rs 13,600 Crore

Mumbai: Mankind Pharma on Thursday said it has entered into a definitive agreement to acquire a 100 per cent stake in Bharat Serums and Vaccines (BSV) from private equity firm Advent International for…

  • Pharma
  • July 27, 2024
  • 52 views
Australian Mayne Pharma Sues Sun Pharma Over Patent Infringement

Canberra: Mayne Pharma has filed a lawsuit against Sun Pharma over infringements of patents related to a certain product used for menopause-related vaginal pain, the Australian drugmaker said on Thursday.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Mankind Pharma Acquires Bharat Serums And Vaccines For Rs 13,600 Crore

Mankind Pharma Acquires Bharat Serums And Vaccines For Rs 13,600 Crore

Australian Mayne Pharma Sues Sun Pharma Over Patent Infringement

Australian Mayne Pharma Sues Sun Pharma Over Patent Infringement

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Indian National Charged With Selling Counterfeit Cancer Drugs

Indian National Charged With Selling Counterfeit Cancer Drugs

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

BIS Sanctioned 82 Medical Device Projects To Develop Standards

BIS Sanctioned 82 Medical Device Projects To Develop Standards